Zevra Therapeutics, Inc. ZVRA Fair value adjustment related to investments
Fair value adjustment related to investments at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept zvra:FairValueAdjustmentOfInvestments.
The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zevra Therapeutics, Inc.'s fair value adjustment related to investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zevra Therapeutics, Inc.'s fair value adjustment related to investments?
- Zevra Therapeutics, Inc. (ZVRA) reported fair value adjustment related to investments of $216K in Q1 2026.
- How has Zevra Therapeutics, Inc.'s fair value adjustment related to investments changed year-over-year?
- Zevra Therapeutics, Inc.'s fair value adjustment related to investments increased by 7100.0% year-over-year, from $3K to $216K.
- What is the long-term trend for Zevra Therapeutics, Inc.'s fair value adjustment related to investments?
- Over 2 years (2023 to 2025), Zevra Therapeutics, Inc.'s fair value adjustment related to investments has grown at a -50.7% compound annual growth rate (CAGR), from -$613K to -$149K.
- What does fair value adjustment related to investments mean?
- Captures the non-cash impact of changes in the market value of investment holdings that are marked-to-market through the income statement. It provides visibility into the volatility of the company's investment portfolio and its impact on reported earnings.